Carbidopa, Levodopa, And Entacapone Tablet, Film Coated
Product Images NDC 0781-5669

9 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa, And Entacapone (NDC 0781-5669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cle_label_01 (Carbidopa Levodopa Entacapone 04)

Cle_label_01 (Carbidopa Levodopa Entacapone 04)
Label for Carbidopa, Levodopa, and Entacapone Tablets containing Carbidopa 12.5 mg, Levodopa 50 mg, and Entacapone 200 mg per film-coated tablet. The package contains 100 tablets. The label includes dosage warnings, storage instructions, manufacturer details (Sandoz Inc), and the product is made in Finland.*
FDA Label Image

Cle_label_02 (Carbidopa Levodopa Entacapone 05)

Cle_label_02 (Carbidopa Levodopa Entacapone 05)
Carbidopa, Levodopa, and Entacapone Tablets label for 100 film-coated oral tablets. Each tablet contains 18.75 mg Carbidopa, 75 mg Levodopa, and 200 mg Entacapone. The label includes usage instructions, storage conditions, and manufacturer details: Orion Corporation for Sandoz Inc. The product is prescription-only and advises not to crush, split, or chew tablets.*
FDA Label Image

Cle_label_03 (Carbidopa Levodopa Entacapone 06)

Cle_label_03 (Carbidopa Levodopa Entacapone 06)
Carbidopa, Levodopa, and Entacapone Tablets label for 100 film-coated tablets. Each tablet contains 25 mg Carbidopa, 100 mg Levodopa, and 200 mg Entacapone. The label includes storage instructions, dosage guidance, manufacturer details (Orion Corporation for Sandoz Inc), barcode, and caution to keep out of reach of children.*
FDA Label Image

Cle_label_04 (Carbidopa Levodopa Entacapone 07)

Cle_label_04 (Carbidopa Levodopa Entacapone 07)
Label for Carbidopa, Levodopa, and Entacapone Tablets, film-coated, with strengths of 31.25 mg Carbidopa, 125 mg Levodopa, and 200 mg Entacapone per tablet. The label notes the product is Rx only, manufactured by Sandoz Inc, with storage instructions and warnings, including to keep out of reach of children. The product is made in Finland by Orion Corporation.*
FDA Label Image

Cle_label_05 (Carbidopa Levodopa Entacapone 08)

Cle_label_05 (Carbidopa Levodopa Entacapone 08)
Label for Carbidopa, Levodopa, and Entacapone Tablets, film-coated, containing Carbidopa 37.5 mg, Levodopa 150 mg, and Entacapone 200 mg per tablet. The package contains 100 tablets and is labeled for prescription use only. The label includes storage instructions, dosage advisories, and manufacturer information for Sandoz Inc.*
FDA Label Image

Cle_label_06 (Carbidopa Levodopa Entacapone 09)

Cle_label_06 (Carbidopa Levodopa Entacapone 09)
Label for Carbidopa, Levodopa, and Entacapone tablets, film-coated, with strengths of 50 mg Carbidopa, 200 mg Levodopa, and 200 mg Entacapone per tablet. The label indicates 100 tablets in the package, manufactured by Sandoz Inc. It includes dosing instructions, storage conditions, and warnings to keep out of reach of children.*
FDA Label Image

Carbidopa_chemstructure (Carbidopa Chemstructure)

Carbidopa_chemstructure (Carbidopa Chemstructure)
Chemical structure of Carbidopa monohydrate, showing the molecular arrangement including hydroxyl groups, hydrazine moiety, and water molecule (H2O) association.*
FDA Label Image

Entacapone_chemstructure (Entacapone Chemstructure)

Entacapone_chemstructure (Entacapone Chemstructure)
Chemical structure diagram showing the molecular structure of the active ingredient in the product Carbidopa, Levodopa, and Entacapone.*
FDA Label Image

Levodopa_chemstructure (Levodopa Chemstructure)

Levodopa_chemstructure (Levodopa Chemstructure)
Chemical structure diagram of the active ingredients Carbidopa, Levodopa, and Entacapone as shown in the image. The structure depicts molecular bonds and functional groups characteristic of these compounds used in combination therapy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.